[Comment] Nedaplatin in nasopharyngeal cancer: the rebirth of platinum salts?

During the past 20 years, three major advances have helped to substantially improve the prognosis of patients with nasopharyngeal carcinoma. First, the use of cisplatin-based concurrent chemoradiation,1 alone2 or with adjuvant3,4 or induction5,6 chemotherapy, has led to improved survival and disease control. Second, the advent of intensity-modulated radiotherapy has allowed treatment volumes to be adapted to the local and regional extension of disease, especially for patients with a posterior extension close to neurological structures, along with better protection of adjacent normal tissues.

Source: The Lancet Oncology - February 28, 2018 Category: Cancer & Oncology Authors: Pierre Blanchard, Yungan Tao Tags: Comment Source Type: research